Home This section contains information regarding the safe administration of REFLUDAN for the treatment of heparin induced thrombocytopenia (HIT) This section contains REFLUDAN prescribing information for the treatment of heparin induced thrombocytopenia (HIT) Site Map Search Contact Us
Refludan [lepirudin (rDNA) for injection] Protect life and limb

Learn more about the benefits of REFLUDAN
This section contains REFLUDAN laboratory and clinical efficacy data
This section contains information regarding the safe administration of REFLUDAN for the treatment of heparin induced thrombocytopenia (HIT)
This section describes the dosage and administration of REFLUDAN in the treatment of heparin induced thrombocytopenia (HIT)
Heparin induced thrombocytopenia
A summary of pivotal trial data for REFLUDAN is covered in this section
This section provides access to a variety of resources to obtain in-depth information on heparin induced thrombocytopenia (HIT) and REFLUDAN

©2007 Bayer Healthcare Pharmaceuticals Inc. All rights reserved.
H.I.T. BACK with REFLUDAN to protect life and limb

REFLUDAN is a bivalent direct thrombin inhibitor proven to significantly reduce the risk of serious consequences of heparin-induced thrombocytopenia (HIT). It is indicated for anticoagulation in patients with HIT and associated thromboembolic disease in order to prevent further thromboembolic complications.




To speak to a specialist who will help answer your questions about REFLUDAN, please call (toll-free) 1-888-84-BAYER (1-888-842-2937).
Terms of Use      Privacy Policy      About Our New Company
Bayer Healthcare Pharmaceuticals